Pharma Data Analytics Engineered for Validation, Privacy, and the Audit Trail
MinervaDB builds and operates the data platforms pharmaceutical and life sciences companies depend on: commercial analytics that joins HCP engagement, prescriptions, and claims under consent, clinical and real-world data platforms with lineage an inspector can follow, manufacturing and quality data from batch records and LIMS, and pharmacovigilance pipelines that never lose a case. Engineered by the team that operates the Oracle, SQL Server, PostgreSQL, SAP HANA, ClickHouse, and cloud warehouse platforms beneath them, under 21 CFR Part 11, GDPR, and HIPAA-class controls.
Pharma Data Analytics Built on Database-Grade Engineering
In life sciences, an analytics platform is inspected as well as used. The question is not only whether the number is right, but whether you can show where it came from, who changed it, and that the patient behind it consented.
Pharma data analytics at MinervaDB is engineered on three commitments that most analytics platforms treat as optional: lineage that reaches the source record, access that follows the data's classification, and change control that matches the data's regulatory weight. Commercial data joins HCP, account, and product masters to prescriptions, claims, and engagement under consent and privacy rules; clinical and real-world data platforms keep provenance from EDC and registries to analysis datasets; manufacturing and quality data from MES, LIMS, and batch records is treated as GxP-relevant with validated pipelines; safety data is handled as a case-level ledger.
The practice sits within our data engineering and data governance work and feeds our decision intelligence, MLOps, and enterprise generative AI practices for life sciences. Our engineers operate the Oracle, SQL Server, PostgreSQL, and SAP HANA systems behind CRM, ERP, LIMS, and safety databases, so a pharma data analytics platform from us is built by people who already carry the operational and validation accountability for the sources.
Pharma Data Analytics Services, End to End
Six workstreams across the value chain, delivered as a bounded programme, embedded engineering, or 24×7 managed data operations.
Commercial Data Platform & HCP 360
Pharma data analytics for the commercial organisation: HCP, HCO, and account masters resolved across CRM, prescription and claims data providers, engagement channels, and medical affairs systems, with consent and channel preferences carried on every record; next-best-action, territory alignment, and launch analytics served from one governed model. Consent and privacy rules enforced at retrieval, not by policy.
Clinical & Real-World Data Platforms
Pharma data analytics for development: pipelines from EDC, CTMS, ePRO, wearables, registries, and claims into standardised analysis models (CDISC SDTM and ADaM, OMOP CDM) with provenance to the source record, de-identification and tokenisation for secondary use, and reproducible analysis environments for biostatistics and epidemiology.
Manufacturing, Quality & Supply Data
Pharma data analytics on the plant floor: batch records, MES, LIMS, deviations, CAPA, and serialisation data on a validated pipeline, with process analytics, golden-batch comparison, release-time reduction, and supply visibility across sites and CMOs. GxP-relevant paths are validated under a risk-based approach with change control that matches the data's weight.
Pharmacovigilance & Safety Data Engineering
Pharma data analytics where a lost record is a regulatory event: case intake from call centres, literature, partners, and digital channels into the safety database with reconciliation that proves no case was lost; signal detection datasets with lineage; and audit-ready reporting for periodic safety reports and inspections.
Privacy, Consent & Compliance Engineering
Column-level classification, de-identification and tokenisation, consent enforcement at query time, row-level security by country and affiliate, and audit logging of every access to identifiable data, mapped to GDPR, HIPAA, India DPDP, and 21 CFR Part 11. Delivered with our data governance consulting practice.
Platform Engineering & Managed Operations
Lakehouse core, warehouse and real-time tiers, semantic layer, validated environments, and 24×7 operations under SLOs, with computer system validation documentation produced from the platform rather than written after the fact.
Where Pharma Data Analytics Lives Along the Value Chain
Each stage has its own systems, its own regulatory weight, and its own definition of a trustworthy number. One platform serves all of them only if it respects those differences.
Regulatory weight decides the engineering. In pharma data analytics a commercial dashboard and a batch-release dataset can share a platform, but not a change-control process. We classify every dataset by its GxP relevance and privacy sensitivity, and the pipeline's validation, access, and audit controls follow from that classification.
Lineage reaches the source record. From an analysis dataset back to the EDC form, from a sales report back to the prescription record, from a signal back to the case: lineage is captured automatically and is the first thing an inspector or an auditor asks for.
Consent travels with the data. HCP and patient consent flags are carried on the record and enforced at retrieval, so an assistant, a notebook, and a dashboard cannot reach data the person did not agree to share.
- Datasets classified by GxP relevance and privacy sensitivity, with controls derived from the classification
- Column-level lineage from analysis datasets to source systems, captured automatically
- Validated pipelines with change control, versioned specifications, and executed test evidence
- De-identification and tokenisation with re-identification keys held separately under access control
- Country and affiliate row-level security reflecting data-transfer and residency rules
- Audit logs of every access to identifiable data, retained per regulatory schedule
The Pharma Data Analytics Platform We Engineer
A lakehouse core with validated and non-validated zones, warehouse and real-time serving tiers, and a governance plane that generates its own evidence.
Validated and Non-Validated Zones on One Lakehouse
Pharma data analytics platforms need two zones. GxP-relevant data (batch, quality, safety, regulatory submissions) lives in a validated zone with change control, executed test evidence, and restricted deployment paths; commercial and exploratory data lives in a non-validated zone with lighter controls. Both share the lakehouse core, catalog, and lineage, so a quality dataset can be analysed alongside supply data without copying it into an unvalidated environment.
Oracle and SQL Server Beneath Safety, LIMS, and CRM
Pharma data analytics inherits its sources: safety databases, LIMS, and many commercial systems run on Oracle or SQL Server, and extraction from them is itself a validated activity when the data is GxP-relevant. Our Oracle and SQL Server practices operate these sources, engineer CDC or scheduled extraction with reconciliation, and document it as evidence.
ClickHouse for Engagement and Supply Views, Warehouses for the Rest
Omnichannel HCP engagement streams and serialisation events are high-volume and time-sensitive; ClickHouse serves them in sub-second time for field and supply teams. Snowflake, BigQuery, or Databricks serve finance, commercial analytics, real-world evidence, and biostatistics workloads, chosen on measured workload and operated through our cloud FinOps practice.
Four Ways to Work With Our Pharma Data Analytics Team
From a bounded assessment to fully managed, validated data operations under a 24×7 SLA.
| Model | Best for | What you receive |
|---|---|---|
| Data Platform & Compliance Assessment | Life sciences companies preparing for inspection, a commercial platform rebuild, an RWE programme, or an AI mandate | Dataset inventory classified by GxP relevance and privacy sensitivity, lineage and access gap analysis, platform and cost baseline, and a sequenced roadmap |
| Domain Platform Build | A commercial data platform, a clinical or RWE platform, a manufacturing and quality data platform, or a safety data pipeline | Reference architecture, pipelines, standard models, masters and consent, semantic layer, validation documentation, and runbooks |
| Managed Data Operations | Lean data teams that need 24×7 coverage for validated pipelines, platforms, and the databases behind them | SLO-backed operations on freshness, completeness, and lineage integrity; incident response under our severity matrix; periodic review and evidence packs |
| Embedded Data Engineering | Sustained programmes across domains, teams that want capability transfer | Senior data engineers integrated with your cadence and your quality system, with specifications and documentation as standing deliverables |
Pharma Data Analytics Operated as an Inspectable System
A platform that cannot show its own lineage and access history is a finding waiting to happen. We run life sciences data platforms with the operating discipline of our 24×7 Remote DBA practice and the evidence discipline of a quality system.
Under managed pharma data analytics operations, every dataset carries SLOs on freshness, completeness (reconciled to the source system, and for safety data proven case by case), and lineage integrity (every published dataset traceable to its sources at the time of publication). Access to identifiable data is logged and recertified on a schedule, and every change to a validated pipeline carries executed evidence.
Incidents follow the same severity model as our database support: a safety case intake pipeline stalling is an S1 with a 15-minute response target; a delayed commercial load is an S2. Every incident closes with a root-cause analysis and, where the data is GxP-relevant, a deviation record. Quarterly, we rehearse the scenarios inspections and privacy law demand: a subject access request, a deletion across every copy, a data-transfer restriction change, and a full lineage walk from a published number to its source.
- 24×7 monitoring of pipeline health, source reconciliation, schema drift, and access anomalies
- Case-level reconciliation for safety intake, proving no case lost or duplicated
- Change control on validated pipelines with versioned specifications and executed tests
- Access recertification and audit-evidence packs generated from platform logs
- De-identification and tokenisation keys rotated and held under separate control
- Runbooks with verification before and validation after every change
What Pharma Data Analytics Makes Possible Once the Foundations Hold
The use cases life sciences companies ask for all depend on the same governed platform. Once it exists they become engineering rather than exception handling.
Omnichannel Engagement & Next-Best-Action
HCP 360 with consent, engagement scoring, and next-best-action served to field and digital channels through our decision intelligence practice.
Launch & Market Access Analytics
Uptake, adherence, and access analytics on prescription and claims data, with territory and segment views refreshed as provider data arrives.
Real-World Evidence
Reproducible cohorts and studies on OMOP-standardised claims, EHR, and registry data with provenance suitable for regulatory submission.
Manufacturing Process & Quality Intelligence
Golden-batch comparison, deviation prediction, and release-time reduction from batch, MES, and LIMS data, with models governed through our MLOps practice.
Safety Signal Detection
Disproportionality and trend analysis on case-level data with lineage, and triage assistance under human review.
Medical & Regulatory Assistants
Private, entitlement-aware retrieval over medical information, SOPs, and regulatory documents through our enterprise generative AI practice, inside your VPC.
Why Life Sciences Companies Choose MinervaDB for Pharma Data Analytics
We operate the source systems and the platform
Most pharma data analytics consulting starts above the database. Our engineers operate the Oracle, SQL Server, PostgreSQL, and SAP HANA systems behind safety, LIMS, CRM, and ERP and the ClickHouse, Snowflake, BigQuery, and Databricks platforms the analytics is served from, so lineage and validation cover the whole path.
Pharma data analytics controls derived from classification
Every dataset is classified by GxP relevance and privacy sensitivity, and its validation, access, and audit controls follow. Commercial teams keep their agility; quality and safety teams get the rigour an inspection expects; nobody pays validation cost on data that does not need it.
Vendor-neutral, measurement-driven
We sell no platform licences and earn no referral fees. Every recommendation names the measurement or regulation that justifies it, and we will say when the estate you already own is the right answer.
Evidence generated, not assembled
Lineage, access logs, reconciliation results, and executed test evidence are produced by the platform continuously, so inspection readiness is a query rather than a project, and knowledge transfer includes the evidence discipline itself.
"In life sciences a number is not trustworthy because it is right. It is trustworthy because you can show where it came from, who touched it, and that the patient behind it agreed."
— The MinervaDB Data Engineering TeamHow a Pharma Data Analytics Engagement Runs
Assess & Classify
Inventory of systems and datasets across commercial, clinical, manufacturing, and safety; classification by GxP relevance and privacy sensitivity; lineage and access gaps; measured platform and cost baseline.
Design
Reference architecture with validated and non-validated zones, standard models, masters and consent design, semantic layer, validation approach, and a staged plan beginning with the highest-value domain.
Build & Validate
Pipelines, models, masters, and serving tiers delivered as code with executed test evidence; reconciliation to source systems; lineage verified end to end; runbooks and evidence packs before go-live.
Operate & Improve
SLO-governed operations, periodic access recertification, inspection rehearsals, model governance through MLOps, and knowledge transfer until your team owns the platform and its evidence.
Pharma Data Analytics: Frequently Asked Questions
What does MinervaDB's pharma data analytics service include?
Commercial data platforms and HCP 360, clinical and real-world data platforms, manufacturing, quality and supply data engineering, pharmacovigilance and safety data pipelines, privacy, consent and compliance engineering, and platform engineering with 24×7 managed operations. Each can be delivered as a bounded assessment, a domain platform build, embedded engineering, or managed data operations.
How do you handle 21 CFR Part 11 and computer system validation?
Pharma data analytics datasets and pipelines are classified by GxP relevance; those in scope run in a validated zone with change control, versioned specifications, executed test evidence, audit trails, and controlled deployment. Validation follows a risk-based approach so effort is spent where the data's regulatory weight demands it, and evidence is generated by the platform rather than written after the fact.
How is patient and HCP privacy protected in the analytics platform?
Identifiable data is classified at column level; de-identification and tokenisation are applied for secondary use with keys held under separate control; consent flags travel with the record and are enforced at retrieval; country and affiliate row-level security reflects transfer and residency rules; and every access to identifiable data is logged and recertified. Controls are mapped to GDPR, HIPAA, and India DPDP.
Which standard data models do you work with?
CDISC SDTM and ADaM for clinical data, OMOP CDM for real-world evidence, and industry-standard commercial and supply models for HCP, product, and serialisation data, alongside a governed semantic layer so commercial, medical, quality, and finance teams read the same definitions.
Can generative AI be used safely on medical and regulatory content?
Yes. Generative AI on a pharma data analytics platform runs inside your VPC, with retrieval that enforces entitlements before the model sees anything, evaluation of groundedness on every change, audit logs of every retrieval and answer, and human review for anything that reaches an HCP or a patient. Our enterprise generative AI consulting practice delivers it on the same governed platform.
Which database platforms do you support in life sciences estates?
Oracle and SQL Server beneath safety, LIMS, and CRM systems; SAP HANA and S/4HANA for ERP, batch, and serialisation; PostgreSQL for masters, consent, and applications; and ClickHouse, Snowflake, BigQuery, and Databricks for analytics, all operated by our 24×7 database practices with validation evidence where the data requires it.
Let's Build a Data Platform Your Inspectors and Your Analysts Both Trust
Talk to a MinervaDB principal consultant about the commercial, clinical, quality, or safety data challenge in front of you. The first conversation is always with an engineer, never a salesperson.
Schedule a Consultation → Download the MinervaDB Corporate Flyer (PDF) →Life Sciences Data Resources from MinervaDB
- Data Governance Consulting: Quality, Master Data, and Compliance
- Database Security Services
- Data Engineering Consulting and Managed Pipelines
- Oracle Database Consulting
- SQL Server Support
- Enterprise Generative AI Consulting
- MLOps Consulting
- CDISC standards
- OHDSI OMOP Common Data Model
- 21 CFR Part 11 (eCFR)